Immediate Impact

1 by Nobel laureates 55 standout
Sub-graph 1 of 22

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
3 intermediate papers

Works of Laura Sánchez-Tejada being referenced

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
2012

Author Peers

Author Last Decade Papers Cites
Laura Sánchez-Tejada 137 60 162 154 11 373
F. Worden 77 136 84 103 11 383
C. S. Killian 58 50 114 97 11 409
Danila Serpico 77 57 121 77 9 393
Lauren Shapiro 81 58 81 73 11 391
Dao Doan 115 26 249 177 11 434
Karin Weijers 218 47 71 114 9 386
Emily Siegel 53 44 110 159 13 362
Katrin Friedbichler 107 16 187 158 13 407
Jessica Giorcelli 99 129 110 98 16 418
Darla Landfair 105 32 238 74 8 364

All Works

Loading papers...

Rankless by CCL
2026